INSIGHTS ON LIQUID DOSE MANUFACTURING

• Advanced Isolator Tech Boosts Manufacturing Efficiency And Quality

  Isolator technology can run continuously over several days, minimizing operator interaction and other opportunities to introduce contamination — ideal for high-volume, time-limited production runs.

• Drug Substance To Fill-Finish Handoff: What Sponsors Need To Know

  Effective drug substance handoff to fill-finish manufacturing depends on early collaboration, clear communication, and proactive planning to reduce risks, ensure quality, and maintain timelines.

• A Simple Method For Cell Growth Media Preparation

  Explore how powder media and sterile fluid handling can reduce contamination risk and improve efficiency in viral vector production, especially for HEK293-based AAV workflows.

• How Can You Avoid Bioprocessing Risks When Using Cable Ties?

  Cable ties in bioprocessing can cause leaks, damage, and delays. See how switching to a uniform-sealing connector can significantly improve efficiency, reduce prep time, and minimize contamination risks.

• De-Risking The Transition From Vial To Drug-Device Combination Product

  7/25/2025

  When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.

• Quadrupling Inspection Speed With Automated Visual Inspection (AVI)

  7/7/2025

  JHS boosted vaccine vial inspection speed 4x with automated visual inspection, improving accuracy, efficiency, and capacity to 20 million vials annually using the Seidenader CS-40.

• Minimizing Particulate Risk

  5/13/2026

  While visible particles often draw immediate attention, visual inspection alone is insufficient, as subvisible particulate matter can pose equally significant risks to patient safety.

• Protecting Your Drug Product

  5/13/2026

  With patient lives depending on every dose, even minor vulnerabilities in containment or delivery systems can have serious consequences for product integrity and patient outcomes.

• Why Lower Endotoxin Levels Matter: Raising The Bar For Patient Safety And Product Quality

  5/12/2026

  Strengthen patient safety and regulatory compliance with comprehensive endotoxin control strategies designed to support the evolving demands of injectable and advanced pharmaceutical products.